You are currently browsing the monthly archive for December 2008.
Our inaugural post includes interviews with Huda Zoghbi, M.D. and Adrian Bird, Ph.D. — two people whose names have become almost synonymous with Rett Syndrome. It was due to Dr. Zoghbi’s tenacity and commitment that the Rett gene, MECP2, was identified in her lab in 1999. After seeing her first Rett patient in 1983 she became determined to find the disorder’s genetic cause. It took 16 years of hard work and determination. Dr. Zoghbi’s efforts ushered in the appearance of Professor Adrian Bird. He had discovered the MeCP2 protein earlier that same decade, years before anyone knew it was related to a human disease. During this decade they have both made many key contributions to the Rett field. Rett Syndrome is high-profile disorder in the neuroscience community, in large part, due to their efforts. They play a key role at RSRT as trustee and advisors.
Huda Zoghbi, M.D. is an internationally renowned physician-scientist at Baylor College of Medicine and an investigator of the Howard Hughes Medical Institute. Click here for the first part of a two-part interview.
Adrian Bird, Ph.D. is the world’s leading expert in the gene MECP2. He is the Buchanan Professor of Genetics at the University of Edinburgh and the Deputy Chair of the Wellcome Trust. Click here to read his interview.